Literature DB >> 16313476

Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.

C Meisinger1, H Löwel, M Heier, A Schneider, B Thorand.   

Abstract

OBJECTIVES: To examine gender-specific associations between gamma-glutamyltransferase (GGT) and incident type 2 diabetes mellitus in a representative population-based sample in Germany.
DESIGN: Prospective population-based study.
METHODS: The study was based on 1851 men and 1836 women (aged 25-64 years) who participated in the first Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA) Augsburg Survey 1984/1985, and who were free of diabetes at baseline. Incident cases of type 2 diabetes were assessed using follow-up questionnaires in 1987/1988, 1997/1998 and 2002/2003 and were validated with medical records. Gender-specific hazard ratios (HRs) were estimated from Cox proportional hazard models.
RESULTS: A total of 172 cases of incident type 2 diabetes amongst men and 109 amongst women were registered during a mean follow-up period of 14.7 years. In both sexes the risk of type 2 diabetes increased with increasing levels of serum GGT. After multivariable adjustment HRs for incident type 2 diabetes across GGT categories (<25th, <50th, <75th, <87.5th and > or =87.5th percentiles) were 1.0, 1.81, 2.37, 3.41 and 4.24 (P-value for trend <0.0001) in men and 1.0, 1.42, 1.48, 1.95 and 2.41 (P-value for trend 0.0179) in women. Obesity appeared to be more strongly associated with type 2 diabetes in women with GGT equal or greater than the median compared to women with GGT below the median. However, in men the association between obesity and type 2 diabetes was almost identical in the two groups.
CONCLUSIONS: The GGT is an important predictor for incident type 2 diabetes in men and women from the general population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313476     DOI: 10.1111/j.1365-2796.2005.01572.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  29 in total

1.  Serum gamma-glutamyl transferase and risk of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Thomas J Wang; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

Review 2.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 3.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

4.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

5.  Serum gamma-glutamyl transferase level and diabetes mellitus among US adults.

Authors:  Charumathi Sabanayagam; Anoop Shankar; Jialiang Li; Cecil Pollard; Alan Ducatman
Journal:  Eur J Epidemiol       Date:  2009-05-17       Impact factor: 8.082

6.  C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China.

Authors:  J Ren; Z C Pang; W G Gao; H R Nan; S J Wang; L Zhang; Q Qiao
Journal:  Exp Diabetes Res       Date:  2010-11-07

7.  Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?

Authors:  D-H Lee; M W Steffes; D R Jacobs
Journal:  Diabetologia       Date:  2007-12-11       Impact factor: 10.122

8.  Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the Multi-ethnic Study of Atherosclerosis (MESA).

Authors:  Ryan D Bradley; Annette L Fitzpatrick; David R Jacobs; Duk-Hee Lee; Nancy Swords Jenny; David Herrington
Journal:  Atherosclerosis       Date:  2014-01-21       Impact factor: 5.162

9.  Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A L C Schneider; M Lazo; C E Ndumele; J S Pankow; J Coresh; J M Clark; E Selvin
Journal:  Diabet Med       Date:  2013-04-12       Impact factor: 4.359

10.  Associations between total serum GGT activity and metabolic risk: MESA.

Authors:  Ryan Bradley; Annette L Fitzpatrick; Nancy S Jenny; Duk-Hee Lee; David R Jacobs
Journal:  Biomark Med       Date:  2013-10       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.